OFF-LABEL DRUG USE IN HOSPITALIZED CHILDREN- A PROSPECTIVE OBSERVATIONAL STUDY AT GONDAR UNIVERSITY REFERRAL HOSPITAL, NORTHWESTERN ETHIOPIA
Author(s)
Tefera YG1, Gebresillassie BM2, Abebe TB3, Mekuria Ab3, Erku DA3, Seid N3, Beshir HB3
1University of Gondar, City, Ethiopia, 2university of gondar, gondar, Ethiopia, 3University of Gondar, Gondar, Ethiopia
OBJECTIVES: This study aimed at determining the extent of unlicensed and off-label drug uses and associated factors in children hospitalized in Gondar University Referral Hospital, Northwest Ethiopia. METHODS: An institution-based prospective cross-sectional study was employed from April 15 to July 15, 2016. A total of 243 pediatric patients admitted to Gondar university referral hospital were included in the study using simple random sampling method. Data were collected using structured questionnaire, and the data collected were entered and analyzed using Statistical Packages for Social Sciences (SPSS) version 20. RESULTS: From the total of 800 drugs prescribed, 607 (75.8%) were off-label. Off-label medicine use was frequently observed in antimicrobials(60.6%) followed by central nervous system drugs (14.3%). The extent off-label prescribing was highest in age group of 6–13 years (30%). Inappropriate dosing and frequency (42.3%) were the most common reason for off-label medicine use. Having other variables controlled, age group and undergoing surgical procedure remained to be significant predictors of off-label prescribing in the multivariate regression analysis. CONCLUSIONS: Implementing evidence-based approach in prescribing by generating more quality literatures on the safety profile and effectiveness of off-label would improve the injudicious use of drugs in pediatric population.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PIH2
Topic
Epidemiology & Public Health
Topic Subcategory
Disease Classification & Coding, Safety & Pharmacoepidemiology
Disease
Infectious Disease (non-vaccine), Multiple Diseases, Respiratory-Related Disorders, Urinary/Kidney Disorders